Genomics and Artificial Intelligence: Prostate Cancer.

Urol Clin North Am

Catherine & Joseph Aresty Department of Urology, Center for Robotic Simulation & Education, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. Electronic address:

Published: February 2024

Artificial intelligence (AI) is revolutionizing prostate cancer genomics research. By leveraging machine learning and deep learning algorithms, researchers can rapidly analyze vast genomic datasets to identify patterns and correlations that may be missed by traditional methods. These AI-driven insights can lead to the discovery of novel biomarkers, enhance the accuracy of diagnosis, and predict disease progression and treatment response. As such, AI is becoming an indispensable tool in the pursuit of personalized medicine for prostate cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2023.06.006DOI Listing

Publication Analysis

Top Keywords

prostate cancer
12
artificial intelligence
8
genomics artificial
4
intelligence prostate
4
cancer artificial
4
intelligence revolutionizing
4
revolutionizing prostate
4
cancer genomics
4
genomics leveraging
4
leveraging machine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!